ferropharma group




About Us

Since 1989, at ferropharma we are changing the health care market by cutting value chains to decrease cost of drug development and drug availability. One of our brands, EMELEMA® - Making Latest Medicine Available - is what we believe in and what drives the best talent from around the globe to join us.  

Our aim is to be known as the company that increases patient access to generic and innovative medicine. We focus on building bridges between markets, stakeholders and patients. Collectively, we believe in finding the most fair, straight and reliable provider for the distribution of Biotechnologies, Finished Dosage Forms (FDF), medical devices, and services. Thanks to our dedicated teams in Brazil, Singapore, India, United Kingdom, Germany, and Malta, we are using manufacturing plants for high quality products, in the most efficient way. We direct our attention on novel delivery systems and the provision of EU registered and manufactured drugs.

We made quality our priority. The EMA, FDA and ANVISA standards for FDFs are our benchmarks that we fulfill. We operate worldwide but our core markets are China, Latin America and the European Union.



Especially for Bio Technology and drug development we focus on the most advanced and innovative regions around the world.


Our history


Hyaluronidase technology

Hyaluronidase technology

ferropharma bio is at the forefront of advancing innovative pharmaceuticals and BioSimilars through our groundbreaking hyaluronidase technology.

Single-Use technology

Single-Use technology

Single-Use technology gives you complete design flexibility in process development.

The power of personal

The power of personal

For all companies in Biotech, attracting and retaining talent is a key success factor

More News

Cell and Gene Therapy (CGT)

Biologics Asia 2023

one nucleus